Safest Antiepileptic in Pregnancy
Lamotrigine and levetiracetam are the safest antiepileptic drugs for use during pregnancy, with lamotrigine showing a 2.0% major malformation rate and levetiracetam 2.4%, compared to valproate's 9.3% 1.
Primary Recommendation
Avoid valproate entirely in women of childbearing potential unless absolutely no alternative exists 2. Valproate carries the highest teratogenic risk among all antiepileptic drugs, with a 5.1-fold increased risk of major malformations compared to lamotrigine 1. It is specifically associated with neural tube defects, hypospadias, cardiac defects, and oral clefts 1.
First-Line Options
Lamotrigine
- Major malformation rate: 2.0% (31 of 1,562 exposures) 1
- Lowest overall teratogenic risk among commonly used antiepileptic drugs
- Seizure control during pregnancy: 31% of women experienced seizures 1
- Note: Recent reports have identified orofacial clefts as a potential concern 3
Levetiracetam
- Major malformation rate: 2.4% (11 of 450 exposures) 1
- Emerging as one of the safest options with reassuring data on congenital malformations and neurocognitive outcomes 4, 5
- Growing body of evidence supports its safety profile 6
Drugs to Avoid or Use with Extreme Caution
Absolutely Contraindicated
Higher Risk Options
- Phenobarbital: 5.5% malformation rate; 2.9-fold increased risk vs. lamotrigine; associated with cardiac defects and oral clefts 1
- Topiramate: 4.2% malformation rate; 2.2-fold increased risk vs. lamotrigine; 1.4% risk of cleft lip specifically 1
- Carbamazepine: 3.0% malformation rate 1
- Phenytoin: 2.9% malformation rate 2, 1
Critical Management Principles
Preconception Planning
- Switch to safer agents before pregnancy - medication adjustment should occur during preconception period 6, 5
- Optimize to monotherapy at lowest effective dose - rates of congenital anomalies relate to higher doses and polytherapy 2
- Start folic acid supplementation: 4 mg daily at least one month before conception and continue through first trimester 2
During Pregnancy
- Continue antiepileptic drugs - the risk of uncontrolled seizures to both mother and fetus outweighs medication risks in most cases 2
- Maintain monotherapy when possible - polytherapy carries greater risks than monotherapy 1, 3
- Use lowest effective dose - teratogenic effects are dose-dependent 2, 3
Important Caveats
The uncontrolled maternal disease poses significant risks: Poorly controlled epilepsy during pregnancy is associated with miscarriage, low birth weight, developmental disabilities, microcephaly, neonatal hypoxia, intrauterine growth restriction, preterm birth, and fetal death 2. Approximately one-third of women with epilepsy experience increased seizure frequency during pregnancy 2.
Not all polytherapy is equally harmful: Some combinations may be acceptable when avoiding valproate and topiramate 4. However, monotherapy remains the goal.
Seizure disorders themselves increase malformation risk: Even without medication, epilepsy is associated with increased risk of congenital anomalies 2.
Breastfeeding
Women taking lamotrigine or levetiracetam may generally breastfeed safely 6. Natural delivery is also typically appropriate for women on these medications 6.